Cite
Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study
MLA
Emine Arman-Kandirmaz, et al. “Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study.” Pediatric Neurology, vol. 110, Sept. 2020, pp. 59–63. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3667e221634f5e89beaedaf076e30b47&authtype=sso&custid=ns315887.
APA
Emine Arman-Kandirmaz, Songül Tezcan, Banu Anlar, Filiz Arioz, Safak Parlak, Bahadır Konuşkan, Ekim Gumeler, Mesut Sancar, & Ibrahim Oncel. (2020). Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study. Pediatric Neurology, 110, 59–63.
Chicago
Emine Arman-Kandirmaz, Songül Tezcan, Banu Anlar, Filiz Arioz, Safak Parlak, Bahadır Konuşkan, Ekim Gumeler, Mesut Sancar, and Ibrahim Oncel. 2020. “Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study.” Pediatric Neurology 110 (September): 59–63. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3667e221634f5e89beaedaf076e30b47&authtype=sso&custid=ns315887.